Patents by Inventor Masami ASHIDA

Masami ASHIDA has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 12643946
    Abstract: To provide an antibody that specifically binds to an extracellular domain of human LPA1, wherein the antibody does not specifically bind to an extracellular domain of human LPA2 and does not specifically bind to an extracellular domain of human LPA3. Preferably, the antibody includes an activity of blocking an LPA1-dependent cell function. Also, a nucleic acid encoding the antibody, a cell including the nucleic acid, and a medicament including the antibody as an active ingredient are provided.
    Type: Grant
    Filed: October 13, 2023
    Date of Patent: June 2, 2026
    Assignees: NB HEALTH LABORATORY CO., LTD., THE UNIVERSITY OF TOKYO
    Inventors: Megumi Hikichi, Masami Ashida, Miki Nakagawa, Masahiko Shinagawa, Ryoma Tanaka, Kiyoshi Takayama, Junken Aoki
  • Publication number: 20250171532
    Abstract: To provide an antibody that specifically binds to an extracellular domain of human LPA1, wherein the antibody does not specifically bind to an extracellular domain of human LPA2 and does not specifically bind to an extracellular domain of human LPA3. Preferably, the antibody includes an activity of blocking an LPA1-dependent cell function. Also, a nucleic acid encoding the antibody, a cell including the nucleic acid, and a medicament including the antibody as an active ingredient are provided.
    Type: Application
    Filed: October 13, 2023
    Publication date: May 29, 2025
    Applicants: NB HEALTH LABORATORY CO., LTD., THE UNIVERSITY OF TOKYO
    Inventors: Megumi HIKICHI, Masami ASHIDA, Miki NAKAGAWA, Masahiko SHINAGAWA, Ryoma TANAKA, Kiyoshi TAKAYAMA, Junken AOKI
  • Patent number: 12208113
    Abstract: To provide a technique for selecting a target cell producing a target substance that specifically binds to a desired cell membrane protein more rapidly and efficiently. A substrate 1 having a plurality of microwells 2 is provided. A first cell 3 expressing a target cell membrane protein on its surface is allowed to adhere to each of the microwells 2. One or two second cells 5 as a candidate of a target cell are introduced into each microwell 2, and are allowed to coexist with the first cell 3 in the microwell 2, and target substance 6 secreted by the second cell 5 is brought into contact with the first cell 3. A microwell 2 including the first cell 3 to which the target substance 6 binds is identified. The second cell 5 as the target cell is recovered from the identified microwell 2. One example of the target substance 6 is an antibody. Visualization may be performed by adding a label substance 7.
    Type: Grant
    Filed: May 11, 2022
    Date of Patent: January 28, 2025
    Assignee: NB HEALTH LABORATORY CO., LTD.
    Inventors: Masami Ashida, Yuji Urushibata, Kiyoshi Takayama
  • Publication number: 20220347202
    Abstract: To provide a technique for selecting a target cell producing a target substance that specifically binds to a desired cell membrane protein more rapidly and efficiently. A substrate 1 having a plurality of microwells 2 is provided. A first cell 3 expressing a target cell membrane protein on its surface is allowed to adhere to each of the microwells 2. One or two second cells 5 as a candidate of a target cell are introduced into each microwell 2, and are allowed to coexist with the first cell 3 in the microwell 2, and target substance 6 secreted by the second cell 5 is brought into contact with the first cell 3. A microwell 2 including the first cell 3 to which the target substance 6 binds is identified. The second cell 5 as the target cell is recovered from the identified microwell 2. One example of the target substance 6 is an antibody. Visualization may be performed by adding a label substance 7.
    Type: Application
    Filed: May 11, 2022
    Publication date: November 3, 2022
    Applicant: NB HEALTH LABORATORY CO., LTD.
    Inventors: Masami ASHIDA, Yuji URUSHIBATA, Kiyoshi TAKAYAMA
  • Patent number: 11357787
    Abstract: To provide a technique for selecting a target cell producing a target substance that specifically binds to a desired cell membrane protein more rapidly and efficiently. A substrate 1 having a plurality of microwells 2 is provided. A first cell 3 expressing a target cell membrane protein on its surface is allowed to adhere to each of the microwells 2. One or two second cells 5 as a candidate of a target cell are introduced into each microwell 2, and are allowed to coexist with the first cell 3 in the microwell 2, and target substance 6 secreted by the second cell 5 is brought into contact with the first cell 3. A microwell 2 including the first cell 3 to which the target substance 6 binds is identified. The second cell 5 as the target cell is recovered from the identified microwell 2. One example of the target substance 6 is an antibody. Visualization may be performed by adding a label substance 7.
    Type: Grant
    Filed: February 17, 2020
    Date of Patent: June 14, 2022
    Assignee: NB HEALTH LABORATORY CO., LTD.
    Inventors: Masami Ashida, Yuji Urushibata, Kiyoshi Takayama
  • Publication number: 20220040216
    Abstract: To provide a technique for selecting a target cell producing a target substance that specifically binds to a desired cell membrane protein more rapidly and efficiently. A substrate 1 having a plurality of microwells 2 is provided. A first cell 3 expressing a target cell membrane protein on its surface is allowed to adhere to each of the microwells 2. One or two second cells 5 as a candidate of a target cell are introduced into each microwell 2, and are allowed to coexist with the first cell 3 in the microwell 2, and target substance 6 secreted by the second cell 5 is brought into contact with the first cell 3. A microwell 2 including the first cell 3 to which the target substance 6 binds is identified. The second cell 5 as the target cell is recovered from the identified microwell 2. One example of the target substance 6 is an antibody. Visualization may be performed by adding a label substance 7.
    Type: Application
    Filed: February 17, 2020
    Publication date: February 10, 2022
    Applicant: NB HEALTH LABORATORY CO., LTD.
    Inventors: Masami ASHIDA, Yuji URUSHIBATA, Kiyoshi TAKAYAMA